Recurrent Uti

SOGC CLINICAL PRACTICE GUIDELINE
SOGC CLINICAL PRACTICE GUIDELINE
No. 250, November 2010

Recurrent Urinary Tract Infection
Abstract
This Clinical Practice Guideline has been prepared by the Urogynaecology Committee, reviewed by the Family Physicians Advisory Committee, and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. PRINCIPAL AUTHORS Annette Epp, MD, Saskatoon SK Annick Larochelle, MD, St. Lambert QC UROGYNAECOLOGY COMMITTEE Danny Lovatsis, MD (Chair), Toronto ON Jens-Erik Walter, MD (Co-Chair), Westmount QC William Easton, MD, Scarborough ON Annette Epp, MD, Saskatoon SK Scott A. Farrell, MD, Halifax NS Lise Girouard, RN, Winnipeg MB Chander Gupta, MD, Winnipeg MB Marie-Andrée Harvey, MD, Kingston ON Annick Larochelle, MD, St. Lambert QC Magali Robert, MD, Calgary AB Sue Ross, PhD, Calgary AB Joyce Schachter, MD, Ottawa ON Jane A. Schulz, MD, Edmonton AB David Wilkie, MD, Vancouver BC FAMILY PHYSICIANS ADVISORY COMMITTEE William Ehman, MD (Chair), Naniamo BC Sharon Domb, MD, Toronto ON Andrée Gagnon, MD, Blainville QC Owen Hughes, MD, Ottawa ON Jill Konkin, MD, Edmonton AB Joanna Lynch, MD, Winnipeg MB Cindy Marshall, MD, Lower Sackville NS Disclosure statements have been received from all members of the committees. The literature searches and bibliographic support for this guideline were undertaken by Becky Skidmore, Medical Research Analyst, Society of Obstetricians and Gynaecologists of Canada. Objective: To provide an update of the definition, epidemiology, clinical presentation, investigation, treatment, and prevention of recurrent urinary tract infections in women. Options: Continuous antibiotic prophylaxis, post-coital antibiotic prophylaxis, and acute self-treatment are all efficient alternatives to prevent recurrent urinary tract infection. Vaginal estrogen and cranberry juice can also be effective prophylaxis alternatives. Evidence: A search of PubMed and The Cochrane Library for articles

References: 1. Czaja CA, Hooton TM. Update on acute uncomplicated urinary tract infection in women. Postgrad Med 2006;119:39–45. 2. Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Self reported incidence of urinary tract infection and associated costs. Ann Epidemiol 2000;10:509–15. 3. Hooton TM. A prospective study for risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996;335:468. 4. Jackson SL, Boyko IJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause. Am J Med 2004;117:903. 5. Gopal M, Northington G, Arya L. Clinical symptoms predictive of recurrent urinary tract infection. Am J Obstet Gynecol 2007;197:74.e1–4. 6. Foster RT Sr. Uncomplicated urinary tract infections in women. Obstet Gynecol Clin North Am 2008;35:235–48. 7. American College of Obstetricians and Gynecologists. Treatment of urinary tract infection in non pregnant women. ACOG Practice Bulletin No. 91, March 2008. Obstet Gynecol 2008;11:785–94. 8. Hooton. Recurrent urinary tract infection in women. Int J Antimicrobial Agents 2001;17:259–268. 9. Kraft JK, Stamey TA. The natural history of symptomatic recurrent bacteruria in women. Medicine 1977;56:55–60. 10. Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infecitons in women. World J Urol 1999;17:415–20. 11. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk fctors for second urinary tract infection among college women. Am J Epidemiol 2000;151:1194–205. 12. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute urinary tract infection? JAMA 2002;287:2701–10. 13. Gupta K, Hooton TM, Roberts PL Stamm WE. Patient-initiated treatment of recurrent urinary tract infection in women. Ann Intern Med 2001;135:9–16. 14. Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis 1999;29:113–9. 15. Mulvey MA, Schilling JD, Jultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001;69:4572–9. 16. Rosen DA, Hooten TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLOS Med 2007;4:e329. 17. Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003;349:259–66. 18. Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 2006;43:e101–8. 19. Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H202-producing Lactobacilli and vaginal E. coli colonization in women with recurrent urinary tract infection. J Infect Dis 1998;178:446–50. 20. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000;182:1177–82. 21. Minardi D, Parri G, d’Anzeo G, Fabiani A, El Asmar Z, Muzzonigro G. Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infections. J Urol 2008;179:947–51. 22. Car J, Sheikh A. Recurrent urinary tract infection in women. BMJ 2003:327:1204. 23. Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ 2006;332:94–7. 24. Lifshitz E, Kramer L. Outpatient urine culture. Does collection technique matter? Arch Intern Med 2000;160:2537–40. 25. Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician 2005;71:1153–62. 26. Drekonja DM, Johnson JR. Urinary tract infections. Prim Care 2008;35:345–67. 27. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551–81. 28. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis. J Am Med Assoc 1999;281: 736–8. 29. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745–58. 30. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999;14:606–9. 31. Gupta K, Hooton TM, Roberts MS, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167(20):2207–12. 32. Franco AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol 2005;19:861–73. 33. Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol 1999;17:359–63. 34. Hooton TM, Stamm WE. Urinary tract infections and asymptomatic bacteriuria in pregnancy. UpToDate 2008; version 16.2 (May 31, 2008). 35. Albert X, Huertas I, Pereiró II, San félix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004;(3):CD001209. 36. Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am 1997;11:719–33. 37. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician 1999;59(5):1225–34,1237. 38. Dwyer PL, O’Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol 2002;14:537–43. 39. Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Am J Med 2002;113(Suppl 1A):35S-44S. 40. Guibert J, Humbert G, Meyrier A, Jardin A, Vallancien G, Piccoli S et al. Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin. Presse Med 1995;24:213–6. 41. Melekos MD, Asbach HW, Gerharz E, Zarakovitis IE, Weingaertner K, Naber KG. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997;157:935–9. 42. Engel JD, Schaeffer AJ. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am 1998;25:685–701. 43. Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA 1990;264:703–6. NOVEMBER JOGC NOVEMBRE 2010 l 1089 SOGC CLINICAL PRACTICE GUIDELINE 44. Stamm WE, Counts GW, Wagner K, Martine D, Gregory D, McKevitt M, et al. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med 1980;92:770–5. 45. Nicolle LE. Prophylaxis: recurrent urinary tract infections in women. Infection 1992; 20(Suppl 3):S203–5. 46. Zhanel GG, Nicolle LE. Effects of sub-inhibitory antimicrobial concentration (sub-MICs) on in-vitro bacterial adherence to uroepithelial cells. J Antimicrob Chemother 1992;29:617–27. 47. Goemaere NNT, Grijm K, ThW van Hal P, Bakker MA. Nitrofurantoin-induced pulmonary fibrosis: a case-report. J Med Case Report 2008;2:169. 48. Nicolle LE, Harding GK, Thomson M, Kennedy J, Urias B, Ronald AR. Efficacy of five year of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. J Infect Dis 1988;157:1239–42. 49. Schaeffer AJ, Jones JM, Flynn SS. Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora. J Urol 1982;127:1128–31. 50. Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:15–20. 51. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;(2):CD005131. 52. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New Engl J Med 1993;329:753–6. 53. Eriksen BC. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180:1072–9. 54. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 2001;183(Suppl 1):S74–6. 55. Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003;36:1362–8. 56. Xu R, Wu Y, Hu Y. Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women. Zhonghua Fu Chan Ke Za Zhi 2001;36:531–3. 57. Schmidt DR, Sobota AE. An examination of the antiadherence activity of cranberry juice on urinary and non-urinary bacterial isolates. Microbios 1988;55:173–81. 58. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of craberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989;33:92–8. 59. Jepson JP, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008;(1):CD 001321. 60. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322(7302):1571–3. 61. McMurdo ME, Bissett LY, Price RJ, Phillips G, Crombie IK. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing 2005;34:256–61. 62. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002;9:1558–62. 63. Waites KB, Canupp KC, Armstrong S, DeVivo MJ. Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury. J Spinal Cord Med 2004; 27:35–40. 64. Aune A, Alreak T, LiHua H, Baerheim A. Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 1998; 16:37–9. 65. Alraek T, Fagerheim U, Baerheim A. Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women. Am J Public Health 2002;92:1609–11. 66. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rational and evidence. World J Urol 2006;24:28–32. 67. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995;23:32–45. 68. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents 2006;28(Suppl 1):S30–4. 69. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent urinary tract infection in women. Scand J Prim Health Care 1994;12:239–43. 70. Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women. Drugs 2006;66:1253–61. 71. Grischke EM, Rüttgers H. Treatment of bacterial infections of the female urinary tract by immunization of the patiets. Urol Int 1987;42:338–41. 72. Uehling DT, Hopkins WJ, Beierle LM, Kryger JV, Heisey DM. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis 2001;183 (Suppl 1): S81–3. 73. Hopkins WJ, Uehling DT. Vaccine development for the prevention of urinary tract infections. Curr Infect Dis Rep 2002;4:509–13. 74. Sundén F, Håkansson L, Ljunggren E, Wullt B. Bacterial interference—is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int J Antimicrob Agents 2006;28(Suppl 1):S26–9. 75. Lipovac M, Kurz C, Reithmayr F, Verhoeven HC, Huber JC, Imhof M. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet 2007;96:192–5. 76. Constantinides C, Manousakas T, Nikolopoulos P, Stanitsas A, Haritopoulos K, Giannopoulos A. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 2004;93:1262–6. 77. Eden CS, Fretr R, Hagberg L, Hull R, Hull S, Leffler H, et al. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 1982;298(5874):560–2. 78. Zopf D, Roth S. Oligosaccharides anti-infectives agents. Lancet 1996;347(9007):1017–21. 79. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989;73:576–82. 80. Pfau A, Sacks TG. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis 1992;14:810–4. 81. Ovalle A, Levancini M. Urinary tract infections in pregnancy. Curr Opin Urol 2001:11:55–9. 82. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207–8. 1090 l NOVEMBER JOGC NOVEMBRE 2010